The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Effect of hybrid immunity and bivalent booster vaccination on omicron sublineage neutralisation
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Neutralization data suggests some of these new subvariants have even more immune escape than the original BA.5 subvariant.
“Neutralization data suggests some of these new subvariants have even more immune escape than the original BA.5 subvariant [43,44].”
From Assessing COVID-19 vaccine effectiveness against Omicron subvariants: Report from a meeting of the World Health Organization (2023) · cites this paper as [43]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection
Cao, Y., Yisimayi, A., Jian, F., Song, W., Xiao, T., Wang, L., Du, S., Wang, J., Li, Q., Chen, X., et al. (2022) · Nature · doi:10.1038/s41586-022-04980-y · Cited by 1,306
Imprinted antibody responses against SARS-CoV-2 Omicron sublineages
Park, Y., Pinto, D., Walls, A. C., Liu, Z., Marco, A. D., Benigni, F., Zatta, F., Silacci-Fregni, C., Bassi, J., Sprouse, K. R., et al. (2022) · Science · doi:10.1126/science.adc9127 · Cited by 230
Scheaffer, S. M., Lee, D., Whitener, B., Ying, B., Wu, K., Liang, C.-Y., Jani, H., Martin, P., Amato, N. J., Avena, L. E., et al. (2023) · Nature Medicine · doi:10.1038/s41591-022-02092-8 · Cited by 169
Omicron sublineage BA.2.75.2 exhibits extensive escape from neutralising antibodies
Sheward, D. J., Kim, C., Fischbach, J., et al. (2022) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(22)00663-6 · Cited by 103
Comparable neutralisation evasion of SARS-CoV-2 omicron subvariants BA.1, BA.2, and BA.3
Arora, P., Zhang, L., Rocha, C., Sidarovich, A., Kempf, A. M., Schulz, S. R., Cossmann, A., Manger, B., Baier, E., Tampe, B., et al. (2022) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(22)00224-9 · Cited by 95
Self-citationAugmented neutralisation resistance of emerging omicron subvariants BA.2.12.1, BA.4, and BA.5
Arora, P., Kempf, A. M., Nehlmeier, I., Schulz, S. R., Cossmann, A., Stankov, M. V., Jäck, H., Behrens, G. M. N., Pöhlmann, S., & Hoffmann, M. (2022) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(22)00422-4 · Cited by 88
Self-citation
Flagged first, then by citations
Research works printed but not linked: 4
- Kurhade, 2022, Low neutralization of SARS-CoV-2 omicron BA.2.75.2, BQ.1.1, and XBB.1 by 4 doses of parental mRNA vaccine or a BA.5-bivalent booster, bioRxiv
- Miller, 2022, Collier A-r Y, et al. Substantial neutralization escape by the SARS-CoV-2 omicron variant BQ.1.1, bioRxiv
- Davis-Gardner, 2022, mRNA bivalent booster enhances neutralization against BA.2.75.2 and BQ.1.1, bioRxiv
- Schmidt, 2020, Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses, J Exp Med, 217, e20201181, 10.1084/jem.20201181 · DOI · Paper page
Cited by
Sorted by citations
Feikin, D. R., Higdon, M. M., Andrews, N., Collie, S., Deloria Knoll, M., Kwong, J. C., Link-Gelles, R., Pilishvili, T., & Patel, M. K. (2023) · Vaccine · doi:10.1016/j.vaccine.2023.02.020 · Cited by 36
Metadata
- Authors
- Hoffmann, M., Behrens, G. M. N., Arora, P., Kempf, A., Nehlmeier, I., Cossmann, A., Manthey, L., Dopfer-Jablonka, A., & Pöhlmann, S.
- Affiliations
- German Primate Center (DE)
- Medizinische Hochschule Hannover (DE)
- Corresponding author
- Hoffmann, Markus
- Venue
- The Lancet Infectious Diseases
- Publisher
- Elsevier BV
- Published
- 2023-01
- Volume
- 23
- Issue
- 1
- Pages
- 25-28
- ISSN
- 1473-3099 (ISSN-L)
- PMC
- PMC9721839
- OpenAlex
- W4310718488
- Cited by
- 66
- References
- 6
- Citations by year
- 2026: 2 · 2025: 12 · 2024: 22 · 2023: 30
- FWCI
- 7.82
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Lancet Infectious Diseases (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- GoeScholar The Publication Server of the Georg-August-Universität Göttingen (Georg-August-Universität Göttingen) (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Social Sciences › Health › Vaccine Coverage and Hesitancy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › vaccines and immunoinformatics approaches
- Keywords
- hybrid immunity, Omicron subvariants, SARS-CoV-2, neutralizing antibodies, spike protein mutations, antibody escape, COVID-19 vaccination, Omicron variant
- MeSH terms
- Antibodies, Viral, Humans, Vaccination, Adaptive Immunity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
